Maralixibat (in precedenza SHP625 o LUM001) ( DrugBank: Maralixibat )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
338	進行性家族性肝内胆汁うっ滞症	1

338. 進行性家族性肝内胆汁うっ滞症

臨床試験数 : 60 / 薬物数 : 26 - (DrugBank : 6) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001211-22-IT (EUCTR)	07/10/2019	02/02/2021	A Placebo-controlled study of Maralixibat in Subjects with Progressive Familial Intrahepatic Cholest ...	MRX-502: Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safet ...	In patients with progressive familial intrahepatic cholestasis (PFIC),impairment of the egress of bi ...	Product Name: Maralixibat (in precedenza SHP625 o LUM001) Product Code: [Maralixibat] INN or Proposed ...	Mirum Pharmaceuticals Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 3	United States;Lebanon;Turkey;Austria;Colombia;United Kingdom;Italy;France;Hungary;Mexico;Canada;Arge ...

First Previous1Next Last